Navigation Links
BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial
Date:8/1/2008

s of age. MS is caused by damage to myelin, the protective sheath surrounding nerve fibers in the central nervous system, which interferes with messages from the brain to the body. Symptoms of MS may include vision problems, loss of balance, numbness, difficulty walking and paralysis. Approximately 40 percent of all MS patients have the secondary progressive form of the disease.

About BioMS Medical Corp.

-------------------------

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, MBP8298 (dirucotide), is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. In December 2007, BioMS entered into a licensing and development agreement granting Eli Lilly and Company exclusive worldwide rights to MBP8298 (dirucotide) in exchange for an $87 million upfront payment, milestone payments and escalating royalties on sales. For further information please visit our website at http://www.biomsmedical.com.

This press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product developm
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. BioMS Medical announces its intention to renew a normal course issuer bid
2. BioMS Medical to present at BioContact 2007
3. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
4. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
5. BioMS Medical announces third quarter 2007 results
6. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
7. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
9. BioMS Medical to present at BIO CEO & Investor Conference
10. BioMS Medical Announces 2007 Year End Results
11. BioMS Medical to present at BioCentury Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., CHANGCHUN, China and LOS ANGELES, Nov. 30 /...ceuticals, Inc. (OTC Bulletin Board: CYXN; ,China ...ing manufacturer, distributor and,retailer of phar... it has,completed preparation for distribution of ...he Chinese government recently formalized the nati...
(Date:11/30/2009)... , SEATTLE, Nov. 30 C...) announced today that its new class of platinum-b...demonstrated a stronger anti-tumor potency and act...ed compounds as well as the ability to overcome ci...lts were presented in a paper titled "Novel Bis-pl...
(Date:11/30/2009)... , AMSTERDAM, November 3...leading publisher of scientific, medical and techn...r re-launch of Embase, its comprehensive biomedica...ords from more than 7,000,active, peer reviewed jo...le in the advancement of new biomedical,and pharma...
(Date:11/27/2009)... PARIS, November 27 S...market Oralair(R) in both adults and children,thro...irst country where,Oralair(R) has been marketed, w...R) is now registered in Austria, Belgium, Bulgaria...many, Greece, Hungary, Ireland, Italy,Latvia, Lit...
Breaking Biology Technology:China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3
...erapeutics (NYSE Alternext US: CXM) and its operat...d that Thomas E. Ahlering, M.D., Professor and Vic...rsity of California, Irvine , and a pioneer in rob...urgical Injury Following Robotic-Assisted Prostate...nternational Robotic Urology Symposium (IRUS) bein...
... CORPORATION , ( NYSE Alternext US: CVM ) ...d September 30, 2008. , , CEL-SCI reported a net ... net loss of $(9,629,657) in fiscal year 2007. Th...2008 was $(0.07) compared to a net loss per common... the loss in 2008 were non-cash expenditures that ...
... Boston Atrial,Fibrillation Symposium, Stereotaxis...ces in remote magnetic ablation that it believes w...ility of its Niobe(R) Magnetic Navigation,System. ...oftware platform,Navigant 3.0, with the QuikCAS(TM...er control and improved EP lab workflow, and its p...
Other Biology Technology:International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCool's New Investigational UroCool System 2International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCool's New Investigational UroCool System 3International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCool's New Investigational UroCool System 4International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCool's New Investigational UroCool System 5International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCool's New Investigational UroCool System 6International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCool's New Investigational UroCool System 7International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCool's New Investigational UroCool System 8CEL-SCI Corporation Announces 2008 Financial Results 2CEL-SCI Corporation Announces 2008 Financial Results 3Stereotaxis Showcases Advancements for Remote Magnetic Ablations 2Stereotaxis Showcases Advancements for Remote Magnetic Ablations 3Stereotaxis Showcases Advancements for Remote Magnetic Ablations 4
(Date:11/30/2009)...vailable in German . , The DFG has approved...h Centres as of 1 January 2010. This decision was ...Bonn. The new centres will initially be funded for...on, 20 percent overhead funding for indirect costs...es, research topics range from modern prostheses t...
(Date:11/30/2009)...2009) Scientists and engineers from two of the na...ll come together Dec. 7 with leading academicians ... blood. , Much like moving oil through a pipelin...th systems need clean, well-functioning pipes (or ... function efficiently. Both industries also are cr...
(Date:11/30/2009)...he inaugural Global Conference on Systems & Enterp...shington, DC, focuses on the convergence of comple...importance to society. , The goal of the con...ty around targeted complex systems, examined by do...ludes Critical Infrastructure Systems, including I...
Breaking Biology News(10 mins):DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9Similarities of pumping blood and oil examined 2Similarities of pumping blood and oil examined 3First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2Mingling Martinis 26amp 3B Mysterious Murder Masquerade at the Whitney to Benefit Carnival of Care 59087 1Mingling Martinis 26amp 3B Mysterious Murder Masquerade at the Whitney to Benefit Carnival of Care 59087 2BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness 59084 1BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness 59084 2BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness 59084 3Coverall Named Among 50 Top Franchises for Minorities for Third Consecutive Year 59081 1Coverall Named Among 50 Top Franchises for Minorities for Third Consecutive Year 59081 2
...ed images of an elusive drug target on the outer w... new information to aid design of novel antibiotic...tions initiated by Staphylococcus aureus and other...Natalie Strynadka, a Howard Hughes Medical Institu...iversity of British Columbia in Vancouver, Canada,...
... fur seals will travel across a colony to actively...lated, rather than mate with local dominant males.... suggest that female choice may be more widespread...strategies enable species to maintain genetic dive...ge and the British Antarctic Survey (BAS) studied ...
...acteria can complicate treatment after many surgic...t Staphylococcus aureus (MRSA), which has been fou...ost-operative complication. In a study published i...almology, researchers found MRSA infections in the...hese are the first cases of MRSA infectious kerati...
Other Biology News:Bacterial walls come tumbling down 2Bacterial walls come tumbling down 3Female Antarctic seals give cold shoulder to local males 2Drug-resistant bacterial infections serious complication after corrective eye surgery 2
... 20-NW cuff pump is a dedicated cuff pump for smal...cuff pump replaces manual inflation and can be use...ms for mouse and rat; from single up to multi-chan...ff pump has adjustable cut-off pressure in 50 mmHg...
...ted sera are specifically depleted of a single com...d protein, the alternative and classical pathways ...l for the detection and quantitation of hemolytica...ave been used to assess complement activation in n...
... light production by luciferase-cDNA transfected c... the development of reporter gene assays in which ...nscription of other genes. The choice of the lucif...sitivity and relatively simple measurement. With t...
...g is a technique used to reveal two distinct antig... Staining Kit is a Zymed polymer double staining d...neously in the same human cell or tissue sample wi...tified using two different primary antibodies from...
Biology Products: